Kroger is now offering Zepbound KwikPen, a multidose version of Eli Lilly’s GLP-1 weight loss drug, at participating retail pharmacy locations.
The rollout marks the first time self-pay patients may be eligible to use Lilly’s savings program for Zepbound at a retail pharmacy, according to a March 13 news release from Kroger.
Pharmacy staff will help patients navigate insurance benefits, manufacturer programs and discount cards to find cost-effective access. Kroger pharmacies also offer GLP-1 patients additional support services, including pharmacist counseling, virtual nutrition care and referrals to providers as needed.
The KwikPen device contains four weekly doses, allowing patients to fill a month’s prescription with a single pen. It was approved by the FDA on Feb. 23 as part of a label expansion for Zepbound, Lilly’s GLP-1 medication for chronic weight management.
Other pharmacy providers are expanding access as well. Amazon Pharmacy began offering the 2.5 mg starter dose of Zepbound KwikPen for $299 per month through its cash-pay model March 9, with same-day delivery available in nearly 3,000 cities.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
